Connection

Dingwei Zhao to Androgen Antagonists

This is a "connection" page, showing publications Dingwei Zhao has written about Androgen Antagonists.
Connection Strength

0.215
  1. CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nat Cancer. 2025 May; 6(5):854-873.
    View in: PubMed
    Score: 0.215
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.